Keep up to date with news from Gamma Gurus — New Products

Gamma Gurus proudly announces an agreement with IBA to market their Radio Pharma Solutions portfolio in Australia & New Zealand. This strengthens our radiopharmaceutical production solutions support to the NM&MMI community including cyclotron produced isotopes for diagnosis and therapy. With over 450 cyclotrons between 3MeV and 235MeV beam energy installed world-wide, including over 100 Cyclone KIUBE cyclotrons, we look forward to extending IBA’s RPS installed base in Australasia.

Late 2022, CIVCO RT and Qfix announced the merger of their two companies to become a joint manufacturer offering the best of both product ranges - "Better Together".  Gamma Gurus is very pleased to announce that we have been selected to carry both Qfix and CIVCO RT lines in the Australian and New Zealand markets.  We look forward to offering expanded options for our customers such as the innovative Alta™, Access™ & Encompass™ (validated for HyperArc™). Qfix – Gamma Gurus

Gamma Gurus is very pleased to announce the signing of an agency agreement with Bruker BioSpin to market their portfolio of Nuclear Molecular Imaging (NMI) products in Australia & New Zealand. This expands our ability to support the preclinical NMI field by adding additional products, including PET/MR, to the already successful Molecubes range that was acquired by Bruker in November 2021. We look forward to introducing these new products to our customers in 2023!

RadTat is the first non-invasive, semi-permanent skin marking for radiation oncology and Gamma Gurus is pleased to be able to offer this innovative product in Australia. RadTats were designed with both patients and providers in mind as a simple and painless alternative to permanent tatoos that will last for up to two weeks with little to no maintenance by patient or care provider. This is not a sticker! RadTat provides a quick, simple solution that lasts! RadTat Semi-permanent Skin Marking – Gamma Gurus

Gamma Gurus is extremely pleased to announce that they have been appointed sales agents for IBA Proton Therapy products in Australia & New Zealand.  IBA is the world leader in Proton Therapy with over 56% of patients worldwide being treated on IBA systems. Currently there are no Proton Therapy centres operating in Australasia and we are very excited about helping to bring this technology to the region. The addition of IBA Proton Therapy also complements Gamma Gurus' existing portfolio of particle therapy solutions which include C-RAD Surface Guidance systems, CIVCO Patient Positioning and Immobilisation, IBA Dosimetry, and NELCO Radiation Doors...